These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2483169)

  • 1. Possible mechanism of immunosuppression by gramicidin S of S antigen-induced experimental autoimmune uveoretinitis.
    Matsushima S; Shichi H
    J Ocul Pharmacol; 1989; 5(3):261-9. PubMed ID: 2483169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by gramicidin S of experimental autoimmune uveoretinitis, pinealitis and autoimmune encephalomyelitis.
    Matsushima S; Yoshitoshi T; Shichi H
    J Ocul Pharmacol; 1990; 6(3):219-26. PubMed ID: 1705277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of polynactins (tetranactin, trinactin and dinactin) on experimental autoimmune uveoretinitis in rats.
    Tanouchi Y; Shichi H
    Jpn J Ophthalmol; 1987; 31(2):218-29. PubMed ID: 3499534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat.
    Mochizuki M; Kawashima H
    Autoimmunity; 1990; 8(1):37-41. PubMed ID: 1717007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
    Laliotou B; Liversidge J; Forrester JV; Dick AD
    Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine-induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis.
    Fujino Y; Okumura A; Nussenblatt RB; Gery I; Mochizuki M
    Clin Immunol Immunopathol; 1988 Feb; 46(2):234-48. PubMed ID: 2962794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
    Usui M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
    Kurose S; Ikeda E; Tokiwa M; Hikita N; Mochizuki M
    Exp Eye Res; 2000 Jan; 70(1):7-15. PubMed ID: 10644416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
    Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
    J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Caspi RR; McAllister CG; Gery I; Nussenblatt RB
    Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive and anti-proliferative effects of a macrotetrolide antibiotic, tetranactin.
    Tanouchi Y; Shichi H
    Immunology; 1988 Mar; 63(3):471-5. PubMed ID: 3258281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
    Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats.
    Gregerson DS; Merryman CF; Obritsch WF; Donoso LA
    Cell Immunol; 1990 Jun; 128(1):209-19. PubMed ID: 2344622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis.
    Ni M; Chan CC; Nussenblatt RB; Mochizuki M
    Autoimmunity; 1990; 8(1):43-51. PubMed ID: 1717008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction].
    Zheng YZ; Yuan LL; Lin JY; Li HQ
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1118-22. PubMed ID: 17415971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides.
    Vrabec TR; Gregerson DS; Dua HS; Donoso LA
    Autoimmunity; 1992; 12(3):175-84. PubMed ID: 1343765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate.
    Osada M; Sakai T; Kuroyanagi K; Kohno H; Tsuneoka H
    Mol Vis; 2014; 20():1518-26. PubMed ID: 25489225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new immunosuppressive agent, FK 506, on the efferent limb of the immune responses.
    Kawashima H; Mochizuki M
    Exp Eye Res; 1990 Nov; 51(5):565-72. PubMed ID: 1701148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.